Is RVTY up or down today?
RVTY is up 2.79% today, last at 124.31. This stock moved +2.79% versus the prior close.
RVTY · Revvity
RVTY (Revvity) is trading at 124.31, up 2.79% on the session. RVTY sits at the 83% mark of its 52-week range, carries a 14-day RSI of 53, and trades above its 50-day average. Over the past month it is up 5.45%.
Leading the coverage: “Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others” (Yahoo, 4d ago). RVTY is -0.41% since story.
RVTY trades on a trailing P/E of 58.0 and is running 6.51% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
RVTY is up 2.79% today, last at 124.31. This stock moved +2.79% versus the prior close.
Leading the coverage: “Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others” (Yahoo, 4d ago). RVTY is -0.41% since story. Dominant story: Revvity to Acquire Human Cell Design to Boost Metabolic Discovery (3 sources, neutral) RSI is 53 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (126 days) · Drag or scroll left for earlier dates
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery - Zacks Investment Research
Revvity Inc. stock gains momentum as UBS adjusts price target and Q2 2026 revenue edges higher - ad-hoc-news.de
Revvity stock heads into the open after a 2.35% slide - ad-hoc-news.de
Revvity (RVTY) Dropped, What Is Behind the Latest Attention? - simplywall.st